Creative BioMart Products & Reviews

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

An extensive collection of recombinant Cluster of Differentiation (CD) proteins, which are key cell surface markers for immunophenotyping, immune function studies, and therapeutic targeting.

A comprehensive portfolio of high-quality resins, columns, buffers, and accessories essential for the purification and analysis of biomolecules across discovery and process development scales.

Manufactured under strict Good Manufacturing Practice guidelines, these proteins are designed for use in preclinical, clinical, and therapeutic applications where quality and regulatory compliance are paramount.

A comprehensive collection of active, recombinant protein kinases, crucial for screening and profiling small molecule inhibitors and studying cellular signaling pathways in disease.

Proteins purified from their natural, endogenous sources, preserving post-translational modifications and complex native structures for biologically relevant research applications.

A diverse range of recombinant proteins and antigens associated with specific physiological or pathological states, supporting discovery, assay development, and diagnostic validation.

Monoclonal and polyclonal antibodies with validated performance for the precise detection of disease biomarkers in a wide range of clinical and research immunoassays.

A diverse collection of proteins engineered for therapeutic use, including cytokines, growth factors, enzymes, and monoclonal antibodies, supporting the development of novel biologic drugs.

A focused set of recombinant immune regulatory proteins, such as PD-1, PD-L1, and CTLA-4, essential for research and drug discovery in cancer immunotherapy and autoimmunity.

A wide array of recombinant human and animal cytokines, chemokines, and interferons for studying immune responses, inflammation, hematopoiesis, and cell communication.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.

Ready-to-use kits providing optimized reagents and protocols for rapid, reliable, and reproducible detection and quantification of specific biological targets or activities.

A portfolio of recombinant immunoglobulins and cell surface proteins serving as critical targets for the development and functional validation of Chimeric Antigen Receptor T-cell (CAR-T) therapies.

Highly specific and sensitive native or recombinant antigens crucial for the development, calibration, and validation of immunoassays and diagnostic test kits.

Recombinant proteins representing well-validated antigens for Antibody-Drug Conjugates (ADCs), facilitating the screening, characterization, and development of these targeted oncology therapeutics.